Literature DB >> 16940888

National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection.

Edmund J Bini1, Sue L Currie, Hui Shen, Norbert Bräu, Warren Schmidt, Bhupinderjit S Anand, Ramsey Cheung, Teresa L Wright.   

Abstract

BACKGROUND: Although HIV testing is recommended for persons with hepatitis C virus (HCV) infection who are at risk for HIV, little is known about HIV testing in this population.
METHODS: Data were prospectively collected in 4364 HCV-infected patients at 24 Veterans Affairs medical centers across the United States, including demographics, risk factors for HIV infection, and self-reported information on HIV testing.
RESULTS: Overall, 76.8% had been tested for HIV at least once, 14.8% were never tested, 6.6% did not know if they were tested, and 1.8% declined to answer. Multivariable analysis identified injection drug use, needlestick injury, sex with a same-sex partner, a greater number of lifetime sexual partners, and sex with an injection drug user as factors that were independently associated with HIV testing. At least one risk factor for HIV infection was present in 84.5% of the 646 patients who were never HIV tested. Among the 3350 subjects who were tested for HIV, 8.4% were positive, 88.3% were negative, 2.4% did not know the results of their test, and 0.9% declined to answer. Multivariable analysis identified African American and Hispanic race/ethnicity, income < or = 10,000 dollars, sex with a same-sex partner, and sex with an injection drug user as the only variables that were independently associated with HIV seropositivity.
CONCLUSIONS: Although a substantial proportion of HCV-infected patients have been tested for HIV, missed opportunities for early diagnosis of HIV infection exist. Public health strategies to improve HIV testing among patients with chronic HCV infection are needed.

Entities:  

Mesh:

Year:  2006        PMID: 16940888     DOI: 10.1097/00004836-200609000-00014

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection.

Authors:  Sascha van Boemmel-Wegmann; Vincent Lo Re; Haesuk Park
Journal:  Dig Dis Sci       Date:  2020-01-14       Impact factor: 3.199

2.  Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.

Authors:  Carrie Reed; Caleb Bliss; Sherri O Stuver; Timothy Heeren; Sheila Tumilty; C Robert Horsburgh; Jeffrey H Samet; Deborah J Cotton
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

3.  Awareness of hepatitis C infection among women with and at risk for HIV.

Authors:  Mardge H Cohen; Dennis Grey; Judith A Cook; Kathryn Anastos; Eric Seaberg; Michael Augenbraun; Pam Burian; Marion Peters; Mary Young; Audrey French
Journal:  J Gen Intern Med       Date:  2007-10-09       Impact factor: 5.128

4.  Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.

Authors:  Kimberly Page-Shafer; Brandee L Pappalardo; Leslie H Tobler; Bruce H Phelps; Brian R Edlin; Andrew R Moss; Teresa L Wright; David J Wright; Thomas R O'Brien; Sally Caglioti; Michael P Busch
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

5.  Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection.

Authors:  Ole S Søgaard; Nicolai Lohse; Lars Østergaard; Gitte Kronborg; Birgit Røge; Jan Gerstoft; Henrik T Sørensen; Niels Obel
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

6.  Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals.

Authors:  Zahid A Butt; Nabin Shrestha; Dionne Gesink; Michelle Murti; Jane A Buxton; Mark Gilbert; Robert F Balshaw; Stanley Wong; Margot Kuo; Jason Wong; Amanda Yu; Maria Alvarez; Hasina Samji; David Roth; Theodora Consolacion; Mark W Hull; Gina Ogilvie; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  Clin Epidemiol       Date:  2018-08-31       Impact factor: 4.790

7.  HIV testing in patients who are HCV positive: Compliance with CDC guidelines in a large healthcare system.

Authors:  Ilan Fleisher; Alexander G Geboy; Whitney Nichols; Sameer Desale; Stephen Fernandez; Peter Basch; Dawn A Fishbein
Journal:  PLoS One       Date:  2021-06-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.